Saltar al contenido
Merck

Comparative studies of doxorubicin and 4'-epidoxorubicin effects on cardiovascular system in rabbits.

Polish journal of pharmacology and pharmacy (1989-11-01)
A Fronczak, J Drzewoski, P Polakowski
RESUMEN

4'-epidoxorubicin (4'-epiDXR) was compared with doxorubicin (DXR) for myocardial effects in rabbits. Histologically, both drugs when given for six weeks induced a high incidence of diffused myocardial damage. The myocardial damage was less evident in rabbits treated with 4'-epiDXR than DXR for 3 weeks. Functionally 4'-epiDXR like DXR significantly reduced cardiac index (CI), stroke index (SI) and mean arterial blood pressure (MAP).

MATERIALES
Referencia del producto
Marca
Descripción del producto

Deslanoside, European Pharmacopoeia (EP) Reference Standard